MiR-107 inhibits CDK6 expression, differentiation, and lipid storage in human adipocytes by Ahonen, Maria A. et al.
Contents lists available at ScienceDirect
Molecular and Cellular Endocrinology
journal homepage: www.elsevier.com/locate/mce
miR-107 inhibits CDK6 expression, differentiation, and lipid storage in
human adipocytes
Maria A. Ahonena, P.A. Nidhina Haridasa, Raghavendra Mysorea, Martin Wabitschc,
Pamela Fischer-Posovszkyc, Vesa M. Olkkonena,b,∗
aMinerva Foundation Institute for Medical Research, Biomedicum 2U, Helsinki, Finland
bDepartment of Anatomy, Faculty of Medicine, University of Helsinki, Finland
cDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany








A B S T R A C T
MicroRNA-107 (miR-107) plays a regulatory role in obesity and insulin resistance, but the mechanisms of its
function in adipocytes have not been elucidated in detail. Here we show that overexpression of miR-107 in pre-
and mature human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes attenuates differentiation and lipid
accumulation. Our results suggest that miR-107 controls adipocyte differentiation via CDK6 and Notch signaling.
CDK6 is a validated target of miR-107 and was downregulated upon miR-107 overexpression. Notch3, a sig-
naling receptor involved in adipocyte differentiation, has been shown to decrease upon CDK6 depletion; Here
Notch3 and its target Hes1 were downregulated by miR-107 overexpression. In mature adipocytes, miR-107
induces a triglyceride storage defect by impairing glucose uptake and triglyceride synthesis. To conclude, our
data suggests that miR-107 has distinct functional roles in preadipocytes and mature adipocytes; Its elevated
expression at these different stages of adipocytes may on one hand dampen adipogenesis, and on the other,
promote ectopic fatty acid accumulation and reduced glucose tolerance.
1. Introduction
Adipocytes execute a major function as regulators of energy meta-
bolism, and the primary function of adipose tissue is to store trigly-
cerides (TG) (Ali et al., 2013). However, adipose tissue is also con-
sidered as a bona fide endocrine organ due to its ability to secrete a
plethora of signaling molecules including cytokines and chemokines
that regulate appetite, lipid mobilization and inflammation (Lefterova
and Lazar, 2009). Storage of excess energy in the form of TG leads to
adipocyte hypertrophy and hyperplasia, causing an increase in adipose
tissue mass and adverse metabolic effects (Rosen and Spiegelman,
2006). On the other hand, a defect in adipocyte lipid storage results in
ectopic storage of fat in liver or muscles leading to insulin resistance or
non-alcoholic fatty liver disease (Simha and Garg, 2006). Adipocyte
differentiation and lipid accumulation are regulated by distinct sig-
naling pathways and transcriptional control cascades. The key tran-
scription factors that regulate adipogenesis are CAAT/enhancer-binding
protein (C/EBP), and peroxisome proliferator activated receptor γ
(PPAR-γ). Insulin, mTOR, Notch and Wnt signaling are known to play
pivotal roles in regulating adipogenesis (Rosen and MacDougald, 2006;
Ross et al., 2004). Studies show that microRNAs (miRNAs) are
important regulators of both adipocyte differentiation and metabolism
(Rottiers and Näär, 2012; Bartel, 2004; Maurizi et al., 2018).
miRNAs are 19–23 nt long non-coding RNAs. They are significantly
involved in the pathogenesis of a plethora of diseases such as cancers,
cardiovascular diseases, diabetes, neurodegenerative disorders and
epilepsy (Thum et al., 2008; Hwang et al., 2013; Karnati et al., 2015).
The enhanced or impaired production and function of miRNAs underlie
changes in metabolic dysregulation during the development of insulin
resistance (Guay et al., 2011; Nakanishi et al., 2009). The regulatory
effects of miRNAs on adipose tissue metabolism are mediated via reg-
ulation of cell differentiation, proliferation, apoptosis and appetite
(Chen et al., 2013). miRNAs that have been connected to insulin re-
sistance, diabetes or obesity include miR-21, miR-221/222, miR-146b,
miR-33a and –b, miR-103, miR-107, miR-192* and miR-143 (Nakanishi
et al., 2009; Xie et al., 2009; Rottiers and Näär, 2012; Kilic et al., 2015;
Mysore et al., 2016). miR-378, -326, −193b, −126, −26a –and a
number of others –regulate adiponectin (AdipoQ), which is an im-
portant regulator and marker of adipogenesis (Ishida et al., 2014;
Santovito et al., 2014; Belarbi et al., 2015). miR-378 and -326 down-
regulate AdipoQ expression, while miR-193b, −126 and −26a en-
hance its expression. miR-103/107 are known to modulate insulin
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sensitivity in mouse models of obesity and their expression is altered in
human fatty liver (Trajkovski et al., 2011). However, the functions of
miR-107 in adipogenesis and lipid storage in adipocytes in murine
models are thus far inconclusive, and very little data is available on
miR-107 function in human adipocytes. A systematic study on the
function of miR-107 in preadipocytes and mature adipocytes has not
been carried out. Therefore, we characterize in this study the effects of
miR-107 on human SGBS adipocyte differentiation and on mature
adipocyte metabolism.
2. Methods
2.1. Cell culture and transfections
To study the regulation of adipogenesis in the presence of miR-107,
Simpson-Golabi-Behmel syndrome (SGBS) preadipocytes were cultured
according to Fischer-Posovszky et al. (2008). Preadipocytes were
transfected for 48 h and further differentiated for 13 days as described
(Wabitsch et al., 2001; Fischer-Posovszky et al., 2008). Transfections
were done with 100 nM miRNA−107 mimic (Qiagen, MSY0000104) or
non-targeting siRNA (Qiagen, 1027280) by using RNAiMax™ reagent
(Thermo Fisher Scientific, Waltham, MA). Transfected and differ-
entiated cells were harvested or used for assay at day 0 or day 13 of
induction depending on the experiments. Mature SGBS adipocytes were
transfected with 200 nM miR-107 mimic or NT on day 13 for 72 h and
further used for experiments.
2.2. Gene expression analyses
Expression of genes was analyzed at mRNA level by qPCR and for
some genes at protein level by western blotting. SGBS cells were cul-
tured and transfected as specified above, after which RNA was isolated
from the cells with Purelink® RNA Mini Kit or miRNeasy® mini kit
(QIAGEN, Gaithersburg, MD), according to the manufacturer's protocol.
cDNA was synthesized from RNA with SuperScript® VILO™ synthesis Kit
(Invitrogen, Carlsbad, CA). Gene expression analyses were done by
qPCR using Roche SYBR-Green® master mix and a LightCycler 480 II
Real-Time PCR system (Roche Applied Science, Penzberg, Germany).
Crossing point (Cp) value was calculated from each amplification curve,
which was normalized to Cp values of housekeeping genes succinate
dehydrogenase complex subunit A (SDHA) and actin. Primer sequences
are specified in Table 1.
For western blotting cells were lysed with RIPA buffer (buffer tris-
HCl 15mM, pH 7.4 containing NP40 1%, sodium deoxycholate 1.25%,
NaCl 150mM, EDTA 1mM and 1% SDS) and equal amounts of protein
were loaded on 10 or 12% sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) (Fast Cast TGX Stain-free) gels. Blotting on
PVDF membranes was carried out with BioRad Transblot system. After
blocking for unspecific antibody binding, blots were probed overnight
with anti-AdipoQ (Sigma A6354), anti-Glut4 (Cell Signaling
Technology 2213), anti-Notch3 (Cell Signaling Technology 2889), anti-
CDK6 (Novus Biologicals NBP1-87262), anti-Hes1 (Santa Cruz 25392),
anti-p-Rb (Cell Signaling Technology 9307) and anti-PLIN2 (Thermo
Scientific PA1-46158) in 5% milk in TBS with 0.1% Tween. Signals
were detected with enhanced chemiluminescence (ECL) (Thermo
Scientific, Waltham, MA or BioRad Clarity Max™) using BioRad
Chemidoc imaging system. Finally, the signal was quantified with
Image Lab by normalizing the band signal to the total protein intensity.
2.3. Lipid droplet staining and triglyceride assay
Transfected SGBS cells on coverslips were washed and fixed with
4% paraformaldehyde in phosphate-buffered saline (PBS). Cells were
then permeabilized with 0.1% Triton X-100 in PBS, after which they
were washed thrice and stained with Bodipy 493/503 for 20 minutes at
room temperature. The coverslips were mounted with Moviol
(Calbiochem, La Jolla, CA) containing 50mg/ml 1,4-Diazabicyclo-
[2.2.2] octane (Sigma–Aldrich) and 5 μg/ml DAPI (Thermo Scientific/
Molecular Probes) to stain the nuclei. Imaging was done with oil 63X
objective and Colibri laser (Zeiss, Oberkochen, Germany) with the same
exposure time for all samples and images were captured with Zen 2
software (Zeiss). Cell number, area and size of lipid droplets were
quantified with Image J. Total triglycerides (TG) in the SGBS adipocytes
were quantified using GPO-PAP TG assay kit (Cobas, Roche/Hitachi,
Tokyo, Japan). TG levels were normalized to total protein content.
2.4. Glucose uptake
Mature SGBS adipocytes were transfected with 200 nM miR-107 or
non-targeting control siRNA for 72 h, followed by treatment with
100 nM insulin for 15min and incubation with 5 μCi/ml [3H]-2-deoxy-
d-glucose (PerkinElmer, Waltham, MA, USA) and 100 μM 2-deox-
yglucose for 10min. Glucose uptake was terminated using ice-cold PBS
and the cells were washed with ice-cold PBS for three times. Adipocytes
were lysed with 0.5% SDS and radioactivity was measured by liquid
scintillation counting.
2.5. Palmitic acid incorporation and triglyceride measurements
Transfected SGBS adipocytes were labeled with [3H]palmitic acid
(Perkin Elmer) in 2% BSA containing culture medium for 2 h. The cells
were then washed and harvested in 2% NaCl. Total lipids were ex-
tracted according to Bligh and Dyer (1959). Lipid classes were sepa-
rated on TLC (Merck) using neutral lipid solvent system (hexane 65:
diethylether 15: acetic acid: 1 water 0.25 V/V). Triolein was used as
marker for TG and diolein for diacylglycerol (DAG). The corresponding
bands were scraped and the radioactivity was measured by liquid
scintillation counting. The counts were normalized to total protein.
Table 1
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3. Results
3.1. miRNA-107 inhibits adipocyte differentiation in human SGBS
adipocytes
miR-107 is upregulated in obesity and connected to insulin re-
sistance; It is reported to affect adipocyte formation but the results are
somewhat inconsistent and the underlying mechanisms have remained
unclear. Therefore, we wanted to confirm the effect of miR-107 on
human SGBS adipocyte differentiation. We transfected SGBS pre-
adipocytes with miR-107 or non-targeting control (NT) siRNA for 48 h
and further differentiated them for 13 days. miR-107 inhibited the
adipocyte differentiation as detected by reduced adipocyte lipid accu-
mulation (Fig. 1A). Total TG in the differentiated adipocytes was sig-
nificantly reduced by 33% in the miR-107 transfected cells (Fig. 1C) as
compared to NT cells. The miR-107 transfected cells differentiated with
very small lipid droplets and the total lipid droplet area was reduced by
53% in miR-107 transfected cells as compared to the controls (Fig. 1B).
3.2. miR-107 attenuates the expression of adipocyte differentiation markers
The inhibition of adipocyte differentiation by miR-107 was con-
firmed by analyzing the expression of known adipocyte differentiation
markers. miR-107 decreased the expression of a mature adipocyte
hallmark gene, AdipoQ, both at protein and mRNA levels when the cells
were transfected in the preadipocyte stage (Fig. 2A–B). The lipid dro-
plet associated protein perilipin 2 (PLIN2) expression was also sig-
nificantly reduced at the protein level (Fig. 2B). Likewise, the mRNA
expression of several other adipocyte markers (Glucose transporter 4
-GLUT4, diacyl glycerol acyl transferase - DGAT1/2, adipocyte fatty
acid binding protein - AP2 and lipoprotein lipase - LPL) was reduced
(Fig. 2A) in the miR-107 transfected cells.
3.3. miR-107 inhibits CDK6 expression leading to impaired adipocyte
differentiation
CDK6 is a validated target of miR-107 and controls adipocyte dif-
ferentiation (Sarruf et al., 2005; Varshney et al., 2014). Therefore, it
was of interest to analyze whether the miR-107 mediated inhibition of
adipogenesis is exerted through CDK6. The expression of CDK6 protein
was significantly decreased upon miR-107 transfection of SGBS pre-
adipocytes (Fig. 3A–B). The phosphorylation status of its downstream
target retinoblastoma protein (Rb) was significantly decreased in miR-
107 transfected preadipocytes (Fig. 3A–B).
3.4. Notch3 and its target gene Hes1 expression is downregulated by miR-
107 in SGBS preadipocytes
Since Notch3 was recently (Sandel et al., 2018) identified to play a
role in adipogenesis and CDK6 is known to regulate Notch3 (Pekkonen
et al., 2014), it was of interest to analyze whether the expression of
Notch3 and its targets were affected. The expression of Notch3 and its
target Hes1 were significantly downregulated in miR-107 transfected
preadipocytes compared to NT, as demonstrated by western blotting
(Fig. 3A).
3.5. miR-107 alters lipid storage in mature SGBS adipocytes
Since miR-107 is increased in the liver of obese human subjects and
regulates insulin sensitivity (Trajkovski et al., 2011), we studied whe-
ther miR-107 enhances lipid accumulation in mature adipocytes. Ma-
ture SGBS adipocytes were transfected with miR-107 or NT and 72 h
later, the total TG content, lipid droplet size and count were measured.
Surprisingly, total TG was decreased by 19% in miR-107 transfected
cells (Fig. 4A) and the average lipid droplet size in miR-107 transfected
adipocytes was 33% smaller than in the NT transfected control
Fig. 1. Effect of miR-107 overexpression on trigly-
ceride storage. A) Lipid droplet staining of mature
SGBS cells transfected as preadipocytes with non-
targeting control siRNA (NT) or miR-107 mimic
(miR-107). B) Average lipid droplet area quantified
from lipid staining. (Approximately 100 cells in each
condition were quantified) C) Triglyceride content on
day 13 when transfected as preadipocytes. The
timeline of transfection (first arrow) and differentia-
tion (second arrow) is shown at the top. The data
represents the mean ± SEM (Two independent ex-
periments in duplicates). Statistical significance is
denoted as **p< 0.01, ***p< 0.001
(Mann–Whitney test).
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adipocytes (Fig. 4B). However, an increase in the total number of lipid
droplets was detected, reflecting an elevated number of small lipid
droplets (Fig. 4C). These observations suggest a defect in lipid droplet
formation in miR-107 transfected mature adipocytes.
3.6. miR-107 transfected adipocytes exhibit a decrease in glucose uptake,
TG synthesis and enhanced inflammatory gene expressions
The defective lipid storage in SGBS mature adipocytes could be due
to decreased glucose uptake and TG synthesis. In miR-107 transfected
adipocytes compared to NT transfected ones, glucose uptake was sig-
nificantly reduced by 38% (Fig. 5A) and palmitic acid (PA) incorpora-
tion to TG was significantly decreased by 48% as compared to NT
transfected control cells (Fig. 5C). A decrease in PA incorporation was
also observed in diacylglycerols, although it did not reach statistical
significance (Fig. 5D). These defects are most likely due to down-
regulation of multiple genes by miR-107 in the transfected cells. GLUT4
expression was decreased in these cells both at mRNA and protein le-
vels. Moreover, a number of genes related to fatty acid and triglyceride
synthesis were downregulated including FAS, DGAT1, DGAT2, CD36,
and SREBP1-C (Fig. 5B). The inflammatory markers tumor necrosis
growth factor α (TNF-α) and interleukin 6 (IL-6) (Fig. 5E) were
upregulated and AdipoQ expression was reduced at the mRNA level
(Fig. 5B). The reduction of AdipoQ at the protein level was not statis-
tically significant, however a decreasing tendency was detectable.
4. Discussion
miR-107 is known to regulate insulin sensitivity in mouse models
mainly by altering liver metabolism (Trajkovski et al., 2011). The
function of adipocyte-expressed miR-107 in adipocyte lipid metabolism
and differentiation is poorly understood, and studies in murine cells and
animal models are inconclusive. When adipocyte miR-107 was directly
injected into mice fat pads, the size of adipocytes increased. On the
contrary, rat stromal vascular cells were not able to efficiently differ-
entiate into adipocytes upon miR-107 overexpression (Trajkovski et al.,
2011). Therefore, a systematic study was required to identify the effect
of miR-107 on adipocyte differentiation and metabolism.
In this study, the effects of miR-107 on adipocyte differentiation
were analyzed by transfecting the SGBS fibroblasts (preadipocytes) and
further differentiating them. The effects of miR-107 in mature adipo-
cytes were studied by transfecting mature SGBS adipocytes. A defect in
adipocyte differentiation and lipid droplet formation were observed in
the cells when they were transfected with miR-107 at preadipocyte
Fig. 2. miR-107 overexpression attenuates adipocyte differentiation. A) mRNA expression of adipocyte differentiation markers after miR-107 transfection. B)
Quantification of protein expression of adiponectin (AdipoQ) and perilipin 2 (PLIN2) in miR-107 overexpressing cells. Non-targeting control is indicated by a dashed
line. Representative immunoblots are shown on the right side; Top: immunodetected bands; below: total protein of the lanes. The data represents the mean ± SEM
(n=4). *p< 0.05, **p< 0.01, ***p< 0.001 (Student's t-test).
Fig. 3. miR-107 inhibits CDK6 expression and downstream signaling. A) Quantification of CDK6, Notch3, p-Rb and Hes1 from western blots of NT or miR-107
transfected preadipocytes. Non-targeting control is indicated by a dashed line. Quantification of western blots and representative western images. B) Top: im-
munodetected bands; below: total protein of the lanes. The data represents the mean ± SEM (n=4). *p< 0.05, **p< 0.01 (Student's t-test).
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stage. The adipogenic differentiation defect was confirmed by analyzing
the expression of differentiation markers like GLUT4, AdipoQ, PLIN2,
DGAT1 and -2, LPL, GLUT4, and aP2 at day 13 of differentiation.
Since CDK6 is a validated target of miR-107 (Feng et al., 2012) and
is implicated to have a role in adipocyte differentiation, the expression
of CDK6 and phosphorylation status of its target Rb were analyzed.
Both CDK6 expression and phosphorylation of Rb were affected by miR-
107 transfection, demonstrating that miR-107 controls CDK6 signaling
in preadipocytes. CDK6 has direct targets that affect adipocyte differ-
entiation, such as PPARγ, (Sarruf et al., 2005). It also phosphorylates
the retinoblastoma protein (Rb), enhancing cultured cells’ commitment
to S-phase. Therefore, inhibition of CDK6 mediated phosphorylation of
Rb could cause G1 phase arrest (Pekkonen et al., 2014). A cell cycle
arrest in the G1 phase has been shown to inhibit differentiation in 3T3-
L1 adipocytes (Ferguson et al., 2016; Auld and Morrison, 2006; Auld
et al., 2007). When CDK6 was silenced, Notch3 and its targets Hes1 and
Hey1, were decreased (Pekkonen et al., 2014). Hes1 and Hey1 are
known to alter adipocyte differentiation and to have both promoting
and inhibitory roles in this process (Ross et al., 2004; Scroyen et al.,
2015). In the present human SGBS model, decrease of Hes1 expression
indicates a proadipogenic role of Hes1. Thus, CDK6 affects several
pathways to promote differentiation (Fig. 6). Notch3 expression is also
reported to be upregulated during adipogenesis (Sandel et al., 2018),
however, silencing of Notch3 in that study did not decrease adipo-
genesis. The observed decrease in Notch3 could thus also be a con-
sequence rather than a cause of the defect in adipogenesis. CDK6 is an
emerging therapy target for obesity due to its role in maintaining white
adipose phenotype. It is also an inhibitor of white to brown adipose
conversion (Hou et al., 2018). This study supports an important role of
CDK6 in adipocyte differentiation. More studies are warranted to clarify
in detail the function of CDK6 in Notch3 signaling and adipocyte me-
tabolism.
We further characterized the effect of miR-107 on mature adipo-
cytes. A defect in TG storage most likely mediated by a decrease in
glucose uptake and impaired TG synthesis was observed. The adipo-
cytes also displayed an elevated inflammatory status, as indicated by
elevated expression of TNF-α and IL-6 and a reduction of AdipoQ
mRNA. Together the data show that the mature adipocytes with an
elevated amount of miR-107 have the potential to become insulin re-
sistant, which could promote impaired glucose tolerance in human
subjects. Genes involved in fatty acid and glucose transport and TG
synthesis were dampened substantiating the phenotype observed. These
data show that, depending on the expression of miR-107 in pre-
adipocytes or mature adipocytes, its consequences on obesity might
differ. In early stages or transition from overweight to obese, miR-107
might prohibit further adipocyte hypertrophy or generation of adipo-
cytes from preadipocytes leading to reduced weight gain. On the other
hand, if miR-107 is elevated in mature adipocytes in obese conditions it
might lead to ectopic fatty acid accumulation and reduced glucose
tolerance due to the defective glucose uptake and storage of fatty acids
in adipocytes. In NAFLD elevated levels of miR-107 are observed in the
liver, leading to reduced insulin sensitivity (Trajkovski et al., 2011).
miR-107 might thus have a higher impact on human obese subjects
with NAFLD than on obese subjects with a normal liver fat content.
In conclusion, miR-107 reduces adipogenesis by downregulating
CDK6 and its downstream targets. In mature adipocytes, miR-107 re-
duced glucose uptake and TG synthesis, suggesting that it may promote
ectopic fatty acid accumulation and reduced glucose tolerance.
Fig. 4. Triglyceride storage and lipid droplet formation are altered upon miR-107 transfection in mature adipocytes. A) Triglyceride quantification (n=4) and
representative lipid droplet staining B) average lipid droplet size and C) number of lipid droplets (200–300 cells in each condition were quantified) in mature
adipocytes transfected with NT or miR-107. The timeline of differentiation (first arrow) and transfection (second arrow) is shown at the top. The data represents the
mean ± SEM. Statistical significance is denoted as *p< 0.05, **p< 0.01 (Mann–Whitney test).
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